Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 15Advanced Solid Tumors 7Solid Tumor 6Solid Tumors 5Advanced Solid Tumor 5Mesothelioma 3Peritoneal Neoplasms 2Advanced Solid Tumours 2Urinary Bladder Neoplasms 1Tracheal Neoplasms 1Thyroid Neoplasms 1Solitary Pulmonary Nodule 1Sarcoma 1Resectable Colon Cancer 1Pulmonary Sclerosing Hemangioma 1Pseudomyxoma Peritonei 1Phyllodes Tumor 1Parathyroid Neoplasms 1Pancoast Syndrome 1Ovarian Neoplasms 1Otorhinolaryngologic Neoplasms 1Osteosarcoma 1Neoplasms 1Myxosarcoma 1Myosarcoma 1Mouth Neoplasms 1Mixed Tumor, Mesodermal 1Mesothelioma, Cystic 1Malignant Solid Tumour 1Malignant Solid Tumor 1

Interventions

adavosertib 5durvalumab 3Paclitaxel 3olaparib 2ceralasertib 2Fluorouracil 2Carboplatin 2toripalimab 1sintilimab 1pembrolizumab 1factor IX, factor VII, factor X, prothrombin drug combination 1drug XX Z 1danvatirsen 1capivasertib 1Rifampin 1Pantoprazole 1Omeprazole 1Leucovorin 1Itraconazole 1Irinotecan 1Injections 1Gemcitabine 1Doxorubicin 1Cisplatin 1AZD0156 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Solid Tumours × Fluorouracil × Other solid neoplasm × Clear all
NCT03421353 2024-08-21

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

AstraZeneca

Phase 1 Completed
76 enrolled
Other solid neoplasm

Advanced Solid Tumours

NCT02588105 2022-09-19

AToM

AstraZeneca

Phase 1 Completed
84 enrolled
Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡